Is MIB-1 proliferation index a predictor for response to neoadjuvant therapy in patients with esophageal cancer?

American Journal of Surgery

Volumn 179, Issue 6, 2000, Pages 514-520

  Imdahl, Andreas ^a   Jenkner, Jost ^a   Ihling, Christian ^a   Rückauer, Klaus Dieter ^a   Farthmann, Eduard Heinrich ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; ESOPHAGUS CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; LONG TERM CARE; MALE; PREDICTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, NUCLEAR; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGE; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROBABILITY; RADIOTHERAPY, ADJUVANT; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0033795046     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(00)00386-X     Document Type: Article

References (27)

1. Vogel S.B., Medenhall W.M., Sombeck M.D., et al. Downstaging of esophageal cancer after preoperative radiation and chemotherapy. Ann Surg. 221:1995;685-695.
2. Forastiere A.A., Heitmiller R.F., Kleinberg L. Multimodal therapy for esophageal cancer. Chest. 112:1997;195S-200S.
3. Duhaylongsod F.G., Gottfried M.R., Iglehart J.D., et al. The significance of c-erb B2 and p53 immunoreactivity in patients with adenocarcinoma of the esophagus. Ann Surg. 221:1995;677-684.
4. Lackey V.L., Reagan M.T., Smith A., Anderson W.J. Neoadjuvant therapy in squamous cell carcinoma of the esophagus role of resection and benefits in partial responders . Ann Thorac Surg. 48:1989;218.
5. Urba S., Orringer M., Turrisi A., et al. A randomized trial comparing surgery to preoperative concomitant chemoradiation plus surgery in patients with resectable esophageal cancer updated analysis . Proc Am Soc Clin Oncol. 16:1997;277.
6. Bosset J.F., Gignoux M., Triboulet J.P., et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell carcinoma of the esophagus. NEJM. 337:1997;161-167.
7. Keller S.M., Ryan L.M., Coia L.R., et al. High dose chemoradiation followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction. Cancer. 83:1998;1908-1916.
8. Fink U., Stein H.J., Wilke H., et al. Multimodal treatment for squamous cell esophageal cancer. World J Surg. 19:1995;198-204.
9. TNM-Klassifikation Maligner Tumoren, UICC 1997, 5. Aufl. Berlin-Heidelberg: Springer; 1997.
10. Naunheim K.S., Petruska P.J., Roy T.S., et al. Preoperative chemotherapy and radiotherapy for esophageal carcinoma. J Thorac Cardiovasc Surg. 103:1992;887-895.
11. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
12. Kockx M.M., Muhring J., Knaapen M.W., de Meyer G.R. RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. Am J Pathol. 152:1998;885-888.
13. Arnott S.J., Duncan W., Gignoux M., et al. Preoperative radiotherapy in esophageal carcinoma a metaanalysis using individual patient data (Esophageal Cancer Collaborative Group) . Int J Radiat Oncol Biol Phys. 41:1998;579-583.
14. Kelsen D.P., Ginsberg R., Pajak T.F., et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. NEJM. 339:1998;1979-1984.
15. Walsh T.N., Noonan N., Hollywood D., et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. NEJM. 335:1996;462-467.
16. Wobst A., Audisio R.A., Colleoni M., Geraghty J.G. Oesophageal cancer treatment studies, strategies and facts . Ann Oncol. 9:1998;951-962.
17. Ganem G., Dubray B., Raoul Y., et al. Concomitant chemoradiotherapy followed, where feasible, by surgery for cancer of the esophagus. J Clin Oncol. 15:1977;701-711.
18. Gerdes J., Li L., Schlueter C., et al. Immunobiochemical and molecular biological characterization of the cell proliferation associated nuclear antigen that is defined by monoclonal antibody Ki67. Am J Pathol. 138:1991;867-873.
19. O'Brian E.R., Alpers C.E., Stewart D.K., et al. Proliferation in primary and restenotic coronary atherectomy tissue implications for antiproliferative therapy . Circ Res. 73:1993;223-231.
20. Ihling C., Menzel G., Wellens E., et al. Topographical association between the cyclin-dependent kinases inhibitor P21, p53accumulation, and cellular proliferation in human atherosclerotic tissue. Arterioscleros Thrombos Vasc Biol. 17:1997;2218-2224.
21. Itaya M, Yoshimoto J, Kojima K, Futagawa S. Usefulness of p53 protein, Bcl-2 protein and Ki67 as predictors of chemosensitivity of malignant tumors. Oncol Rep. 1999;6:675-682.
22. Sarbia M., Bittinger F., Porschen R., et al. The prognostic significance of tumour cell proliferation in squamous cell carcinoma of the oesophagus. Br J Cancer. 74:1996;1012-1016.
23. Youssef E.M., Matsuda T., Takada N., et al. Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus. Cancer. 76:1995;358-366.
24. Moreira L.F., Naomoto Y., Hamada M., et al. Assessment of apoptosis in esophageal carcinoma preoperatively treated by chemotherapy and radiotherapy. Anticancer Res. 15:1995;639-644.
25. Katada N., Hinder R.A., Smyrk T.C., et al. Apoptosis is inhibited early in the dysplasia-carcinoma sequence of Barrett esophagus. Arch Surg. 137:1997;728-737.
26. Wang L.D., Zhou Q., Yang W.C., Yang C.S. Apoptosis and cell proliferation in esophageal precancerous and cancerous lesions study of a high-risk population in northern China . Anticancer Res. 19:1999;369-374.
27. Lee H.S., Park H.J., Lyons J.C., et al. Radiation-induced apoptosis in different pH environments in vitro. Int J Radiat Oncol Biol Phys. 38:1997;1079-1087.